MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
NVIDIA
NVDA
US Stock MarketDetailed Quotes
PDSB PDS Biotechnology
- 1.800
- +0.070+4.05%
Close Jan 3 16:00 ET
- 1.710
- -0.090-5.00%
Post 20:01 ET
67.34MMarket Cap-1.54P/E (TTM)
1.820High1.720Low136.46KVolume1.750Open1.730Pre Close241.99KTurnover0.38%Turnover RatioLossP/E (Static)37.41MShares6.68052wk High3.06P/B64.84MFloat Cap1.53052wk Low--Dividend TTM36.02MShs Float17.850Historical High--Div YieldTTM5.78%Amplitude0.615Historical Low1.773Avg Price1Lot Size
PDS Biotechnology News
A. G. P. Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Cuts Target Price to $4.5
HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $21 Price Target
Promising Advancements in Cancer Treatment Drive Buy Rating for PDS Biotechnology
Express News | PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PDS Biotechnology Corporation Announces Key Opinion Leader Event on HPV16-Positive Head and Neck Cancer and Phase 3 Clinical Trial for Versamune HPV
PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 P.m. ET
PDS Biotechnology Analyst Ratings
B.Riley Financial Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Cuts Target Price to $7
Strategic Changes in PDS Biotechnology's Clinical Trial Design Position Stock as Attractive Buy Opportunity
Express News | PDS Biotechnology Corp : B. Riley Cuts Target Price to $7 From $9
Earnings Preview: PDSB to Report Financial Results on November 14
$PDS Biotechnology(PDSB.US)$ is scheduled to release its financial results on November 14 ET. Earnings PreviewAnalysts estimate $PDS Biotechnology(PDSB.US)$ to post revenue of USD0 for 2024Q3, EPS
PDS Biotechnology Price Target Maintained With a $21.00/Share by HC Wainwright & Co.
Noble Financial Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $17
PDS Biotechnology | 10-Q: Q3 2024 Earnings Report
12 Health Care Stocks Moving In Thursday's Pre-Market Session
PDS Biotechnology Shares Down 18% After Phase 3 Trial Modifications
PDS Biotechnology Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Financial Results.
PDS Biotechnology Corporation (PDSB) Q3 2024 Earnings Call Transcript Summary
PDS Biotechnology Corporation (PDSB) Q3 2024 Earnings Call Transcript
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.